Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation
Jasmeet S. Reyat(Cardiovascular Institute Hospital), Larissa Fabritz(University of Birmingham), Andrew P. Holmes(Cardiovascular Institute Hospital), Stefan Kääb(LMU Klinikum), Moritz F. Sinner(LMU Klinikum), Anika Witten(University of Münster), Paulus Kirchhof(University of Birmingham), Peter Kastner(Roche Pharma AG (Germany)), Monika Stoll(Kiel University), Victor Roth Cardoso(University of Birmingham), Davor Pavlović(University of Birmingham), Joris R. de Groot(Amsterdam University Medical Centers), Winnie Chua(University of Birmingham), S. Nashitha Kabir(Cardiovascular Institute Hospital), Georgios V. Gkoutos(University of Cambridge), Robin Wesselink(Amsterdam Neuroscience)
Cited by 93
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|EP Europace|2016|6.5k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|European Heart Journal|2016|6.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k